Cell Counting Market: Applications of cell counting in personalized medicine
The global cell counting market is projected to reach USD 14.5 billion in 2025 from USD 10.4 billion in
2020, at a CAGR of 6.7 % during the forecast period.
Cell Counting Market growth is largely driven by factors such as growing funding for cell-based research,
rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical
industries, the development of enhanced solutions and improved image analysis, and the growing use of
high-throughput flow cytometry and automated hematology analyzers.
On the other hand, the high cost of cell analysis is expected to hinder market growth to a certain extent.
By application, the research application segment accounted for the largest share of the cell counting
On the basis of application, the cell counting market is segmented into research, medical, and industrial
applications. In 2019, research applications accounted for the largest share of the market. Increasing
government initiatives in stem cell research and the wide usage of cell counting in research are the
major factors driving the growth of the research applications segment.
Download a PDF Brochure @
By end user, the research institutes segment accounted for the largest share of the cell counting
On the basis of end users, the cell counting market is segmented into research institutes, hospitals &
diagnostic laboratories, pharmaceutical & biotechnology companies and CROs, and other end users. In
2019, research institutes accounted for the largest share of the market. The large share of this segment
can primarily be attributed to the growing regulatory approvals for cell culture-based vaccines,
increasing pharmaceutical R&D expenditure, and commercial expansion of various pharmaceutical
By region, North America accounted for the largest share of the cell counting market
In 2019, North Ameri